New prostate implant aims to ease bathroom troubles

NCT ID NCT06136819

Ongoing Disease control Sponsor: Resurge Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a new device called RT-310, a small implant placed inside the prostate to treat bothersome urinary symptoms from an enlarged prostate. The trial includes 20 men aged 50 to 80 who have not gotten enough relief from medication. The main goal is to check if the implant is safe and feasible, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RT-310 implant
What this could lead to: If it works, this could offer a new, less invasive option to relieve frequent or urgent urination caused by an enlarged prostate.
What could go wrong: This is a very early, small safety study with only 20 men. It is not designed to prove the implant works, and side effects or lack of benefit are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BPH (BENIGN PROSTATIC HYPERPLASIA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BPH (BENIGN PROSTATIC HYPERPLASIA) LOWER URINARY TRACT SYMPTOMS

Contacts and locations

Locations

Australian Clinical Trials

Wahroonga, New South Wales, 2076, Australia
Goldfields Urology

Bendigo, Victoria, 3550, Australia
Tauranga Urology Research

Tauranga, North Island, 3112, New Zealand
Western Urology

Maribyrnong, Victoria, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.